NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$14.22
Tradestie Score
55
Market Cap
$2.01B
Revenue Growth
-0.1%
Analyst Upside
+85.3%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.59
|
$2.33B | - | 63 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$41.23
|
$2.33B | - | 57 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.56
|
$2.23B | - | 58 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.06
|
$2.22B | - | 60 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.59
|
$2.21B | - | 63 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.68
|
$2.18B | - | 63 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.44
|
$2.08B | - | 63 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.95
|
$2.02B | 58.6 | 57 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.87
|
$1.97B | - | 63 | Compare |
More NTLA Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2835)
234 stocks in this industry